Hillsdale Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-166,300
| Closed | -$2.28M | – | 664 |
|
|
2024
Q4 | $2.28M | Buy |
166,300
+13,120
| +9% | +$180K | 0.12% | 208 |
|
|
2024
Q3 | $4.2M | Buy |
153,180
+2,000
| +1% | +$54.8K | 0.32% | 101 |
|
|
2024
Q2 | $3.7M | Buy |
+151,180
| New | +$3.7M | 0.29% | 126 |
|
|
2022
Q2 | – | Sell |
-27,000
| Closed | -$680K | – | 590 |
|
|
2022
Q1 | $680K | Sell |
27,000
-3,000
| -10% | -$75.6K | 0.04% | 311 |
|
|
2021
Q4 | $828K | Sell |
30,000
-8,000
| -21% | -$221K | 0.06% | 281 |
|
|
2021
Q3 | $1.23M | Sell |
38,000
-2,000
| -5% | -$64.6K | 0.09% | 182 |
|
|
2021
Q2 | $1.22M | Buy |
+40,000
| New | +$1.22M | 0.1% | 191 |
|
|
2013
Q4 | – | Sell |
-300
| Closed | -$7K | – | 567 |
|
|
2013
Q3 | $7K | Hold |
300
| – | – | ﹤0.01% | 489 |
|
|
2013
Q2 | $8K | Buy |
+300
| New | +$8K | ﹤0.01% | 475 |
|